![Ellen Cavaleri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ellen Cavaleri
Investor Relations Contact chez
PTC THERAPEUTICS, INC.
Profil
Ellen Cavaleri is currently Head-Investor Relations at PTC Therapeutics, Inc. since 2024.
Formerly, worked as Senior VP-Investor Relations & Communications at Lyra Therapeutics, Inc. from 2022 to 2024, and served as Investor Relations Contact at Kadmon Holdings, Inc. Education includes an undergraduate degree from Vanderbilt University and an MBA from New York University.
Postes actifs de Ellen Cavaleri
| Sociétés | Poste | Début |
|---|---|---|
| PTC THERAPEUTICS, INC. | Investor Relations Contact | 01/11/2024 |
Anciens postes connus de Ellen Cavaleri
| Sociétés | Poste | Fin |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Investor Relations Contact | 01/06/2024 |
| KADMON HOLDINGS, INC. | Investor Relations Contact | - |
Formation de Ellen Cavaleri
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Choisissez Zonebourse 
